65347-61-7

Usage

Uses

Used in Pharmaceutical Research:
4-(2-METHYL-3-INDOLYL)PIPERIDINE is used as a research compound for its potential pharmacological properties, which may contribute to the development of novel drugs.
Used in Drug Discovery and Development:
4-(2-METHYL-3-INDOLYL)PIPERIDINE is used as a building block in the synthesis of new pharmaceutical compounds, potentially leading to the creation of innovative medications.
Used in Chemical Synthesis:
In the chemical industry, 4-(2-METHYL-3-INDOLYL)PIPERIDINE may be utilized as an intermediate in the synthesis of complex organic molecules, given its unique structural features.

InChI:InChI=1/C14H18N2/c1-10-14(11-6-8-15-9-7-11)12-4-2-3-5-13(12)16-10/h2-5,11,15-16H,6-9H2,1H3

Downstream Products

• 1198318-45-4 4-(4-methoxyphenyl)-2-{4-[4-(2-methyl-1H-indol-3-yl)-piperidin-1-yl]-butyl}-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine-1,3-dione 
• 1198318-41-0 4-(2-fluorophenyl)-2-{4-[4-(2-methyl-1H-indol-3-yl)-piperidin-1-yl]-butyl}-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine-1,3-dione 
• 1198318-47-6 4-(2-chlorophenyl)-2-{4-[4-(2-methyl-1H-indol-3-yl)-piperidin-1-yl]-butyl}-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine-1,3-dione 
• 1198318-42-1 2-{4-[4-(2-methyl-1H-indol-3-yl)-piperidin-1-yl]-butyl}-4-phenyl-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine-1,3-dione 
• 1198318-48-7 4-(4-fluorophenyl)-2-{4-[4-(2-methyl-1H-indol-3-yl)-piperidin-1-yl]-butyl}-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine-1,3-dione 

Relevant academic research and scientific papers

INDOLE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS

Disclosed are novel compounds of the formula I wherein M1 is CH or N and M2 is C(R3) or N; R1 is optionally substituted indolyl or an aza derivative thereof; R2 is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I in combination with a H1 receptor antagonist.

Novel 1,4-benzodioxanes

Novel 1,4-benzodioxanes of the formula STR1 wherein R' is selected from the group consisting of hydrogen, alkoxy of 1 to 5 carbon atoms, chlorine, bromine and fluorine, R1 and R2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms and Y and Z are hydrogen or together form a double bond in the form of their racemic mixtures or optically active isomers and their non-toxic, pharmaceutically acceptable acid addition salts having antihypertensive activity and a novel process and novel intermediates for their preparation.